Antitumor effects of arsenic disulfide on the viability, migratory ability, apoptosis and autophagy of breast cancer cells

Abstract

In the present study, the antitumor effects of arsenic disulfide (As2S2) on the proliferative, survival and migratory ability of human breast cancer MCF-7 and MDA-MB-231 cells were investigated, and its potential underlying molecular mechanisms with an emphasis on cell cycle arrest, apoptosis induction, autophagy induction and reactive oxygen species (ROS) generation were determined. The results indicated that As2S2 significantly inhibited the viability, survival and migration of breast cancer cells in a dose-dependent manner. In addition, it was identified that As2S2 induced cell cycle arrest primarily at G2/M phase in the two breast cancer cell lines by regulating the expression of associated proteins, including cyclin B1 and cell division cycle protein 2. In addition to cell cycle arrest, As2S2 also triggered the induction of apoptosis in cells by activating the expression of pro-apoptotic proteins, including caspase-7 and −8, as well as increasing the B-cell lymphoma 2 (Bcl-2)-associated X protein/Bcl-2 ratio, while decreasing the protein expression of anti-apoptotic B-cell lymphoma extra-large. In addition, As2S2 stimulated the accumulation of microtubule-associated protein 1A/1B-light chain 3 (LC3)-II and increased the LC3-II/LC3-I ratio, indicating the occurrence of autophagy. As2S2 treatment also inhibited the protein expression of matrix metalloproteinase-9 (MMP-9), but increased the intracellular accumulation of ROS in the two breast cancer cell lines, which may assist in alleviating metastasis and attenuating the progression of breast cancer. Taken together, the results of the present study suggest that As2S2 inhibits the progression of human breast cancer cells through the regulation of cell cycle arrest, intrinsic and extrinsic apoptosis, autophagy, MMP-9 signaling and ROS generation.

A predicted risk score based on the expression of 16 autophagy‑related genes for multiple myeloma survival

“…Autophagy is the process of transporting damaged, denatured or aging proteins, and organelles into lysosomes for digestion and degradation. Under normal physiological conditions, autophagy helps cells to maintain a self-stable state; however, during stress, autophagy prevents accumulation of toxic or carcinogenic damaged proteins and organelles, and inhibits cell carcinogenesis (1)(2)(3)(4). Once a tumor is formed, autophagy can be harmful as cells provide additional nutrients and promote tumor growth.…”

Involvement of autophagy in realgar quantum dots (RQDs) inhibition of human endometrial cancer JEC cells

“…We have used autophagy inhibitors 3-MA and autophagy inducer rapamycin to study RQDs’ effect and found the effect of RQDs induced autophagy cannot be repressed by 3-MA, nor enhanced by rapamycin ( Fig. S2 ), Suggesting that RQDs may be a special autophagy inducer ( Zhao et al, 2019 ).…”

Sources of ROS Species an Its Harmful and Benefical Effects on Human Health<strong> </strong>

“…The study thus suggests the arsenic sulphide acts as an anti breast cancer agent by inducing apoptosis through both of its pathways i.e extrinsic and intrinsic , arrest the cell cycle at its phases, induce autophagy regulates protein expression of metalloproteinase-9 (MMP-9) and its signaling along with the production of ROS. (59) In BC Notch signaling pathway is also involved. Sibilin downregulates the overexpressed Notch-1/ERK/Akt Signaling by the use of ROS and kill the cancer cells of two breast cancer cell lines MCF7 and MDA-MB-231.…”